Загрузка...
4CPS-183 Off-label rituximab in neurology patients
BACKGROUND: Rituximab is an anti-CD20 monoclonal antibody. Its off-label use has increased in the management of a variety of neurologic diseases. PURPOSE: To describe rituximab prescriptions in the Neurology Department, and evaluate the scientific evidence in off-label indications to rationalise its...
Сохранить в:
| Опубликовано в: : | Eur J Hosp Pharm |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMJ Group
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535240/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.273 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|